Skip to main content

Animations

MJFF Publications

1771 - 1780 of 9033 Results
Title
Year
  • Year
  • 2018
  • 2017
  • 2014
  • 2017
  • 2012
  • 2011
  • 2014
  • 2018
  • 2016
  • 2009
  • Hypercholinergic activity in LRRK2 Parkinson's disease
    2018
    Summary Details
    RESTRICTED
    Title: Hypercholinergic activity in LRRK2 Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30073-5
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2017.6669
    Citation Count: 471
  • Summary Details
    OPEN
    Title: Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s Disease
    Journal Name: Lung
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00408-014-9584-7
    Citation Count: 94
  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    2017
    Summary Details
    OPEN
    Title: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4
    Citation Count: 838
  • Summary Details
    OPEN
    Title: Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies
    Journal Name: mAbs
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.4161/mabs.21696
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Repeatability of Aerobic Capacity Measurements in Parkinson Disease
    Journal Name: Medicine & Science in Sports & Exercise
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis Toxin
    Journal Name: Mediators of Inflammation
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2014/358218
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease
    Journal Name: Metabolites
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/metabo8040071
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: Two-Pore Channels and Parkinson's Disease: Where's the Link?
    Journal Name: Messenger
    Publisher: American Scientific Publishers
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1166/msr.2016.1051
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem Cells
    Journal Name: Methods in Molecular Biology
    Publisher: Humana Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-60761-369-5_19
    Citation Count: 99
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.